Company / Operating Income
Fortress Biotech, Inc. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$110.4M
FY2025
5-year range
-$203.6M / -$94.3M
FY2021-FY2025
Trend
+22.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has fluctuated over the past 10 years, ranging from -$204M in FY2023 to -$21M in FY2016.
Based on SEC 10-K filings.
-$110M in FY2025.
Improved from -$204M to -$110M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 22.5% year-over-year.
- Peak operating income was recorded in FY2016.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$110.4M | +22.5% |
| FY2024 | -$142.3M | +30.1% |
| FY2023 | -$203.6M | -8.0% |
| FY2022 | -$188.5M | -100.0% |
| FY2021 | -$94.3M | +14.9% |
| FY2020 | -$110.8M | +7.6% |
| FY2019 | -$120.0M | -33.6% |
| FY2018 | -$89.8M | -77.7% |
| FY2017 | -$50.5M | -144.7% |
| FY2016 | -$20.7M | +42.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026